NeoGenomics Inc. News
Why I Sold My Invitae Stock
The genetic testing company has been unprofitable as it spent heavily (but that's only part of the story).
'Mad Money' Lightning Round: JetBlue, American Electric Power
Jim Cramer’s bullish on JetBlue and American Electric Power, but takes a pass on Jumia Technologies.
Cramer's Mad Money Recap: UnitedHealth Group, Goldman Sachs
Jim Cramer says investors are taking a breather on cyclicals and turning their attention back to technology and healthcare stocks.
When Bad News Is Good News: Cramer's 'Mad Money' Recap
Disappointing payroll data report gives the Fed room to cut interest rates, says Jim Cramer. He's got your game plan for next week.
Yeti Holdings, Neogenomics, Nutanix: 'Mad Money' Lightning Round
Jim Cramer takes a closer look at Yeti Holdings, Neogenomics, Nutanix, Cadence Systems and more.
Micron Stock Tumbles On Grim Chip Sector Outlook After Q3 Earnings Beat
"We saw a significant reduction in near-term industry bit demand, primarily attributable to end demand weakness in consumer markets," said CEO Sanjay Mehrotra.
Tesla Q2 Deliveries In Focus Following Record Quarterly Stock Slump, China Shutdowns
Tesla will publish Q2 deliveries over the coming days following the biggest three-month decline on record for shares of the world's most-valuable carmaker.
Kohl's Stock Plunges As Retailer Scraps Franchise Group Sale Talks
"Given the environment and market volatility, the Board determined that it simply was not prudent to continue pursuing a deal," said chairman Peter Boneparth.
General Motors Stock Halted, Leaps Higher After Detailing Q2 Chip Shortage Hit To Inventory
GM said chip shortages and supply chain snarls left nearly 100,000 vehicles unfinished over the second quarter.